Jun 18, 2021

Latest testing confirms Viraleze highly effective against Alpha, Beta and Gamma COVID variants

Latest testing confirms Viraleze highly effective against Alpha, Beta and Gamma COVID variants

Markets Insider features Starpharma's latest announcement, ..."The results hold significant promise for Viraleze™ – developed by Melbourne-based biopharmaceutical company Starpharma (ASX: SPL) – in the fight against new and emerging variants of SARS-CoV-2, as several countries begin their long-awaited opening of international borders..." Read the full article here

 This contains certain forward-looking statements.